Characterization of the progressive sublines derived from a weakly malignant cloned cell line, ER-1, co-inoculated subcutaneously with a foreign body

Clinical and Experimental Metastasis

Volumn 16, Issue 3, 1998, Pages 291-298

  Hamada, Jun Ichi ^a   Nagayasu, Hiroki ^a   Kawano, Takashi ^a   Mizutani, Tetsuya ^a,b   Nakata, Daichi ^a   Hosokawa, Masuo ^a   Takeichi, Noritoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

In vitro invasion; Malignant progression; Rat mammary carcinoma

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; BREAST CARCINOMA; CANCER INVASION; CELL CLONING; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; FIBROBLAST; FOREIGN BODY; NONHUMAN; RAT; TUMOR GROWTH;

ANIMALS; CELL COMMUNICATION; CELL DIVISION; CHEMOTAXIS; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FIBRONECTINS; GELATINASES; INTERCELLULAR JUNCTIONS; LAMININ; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PLASMINOGEN ACTIVATORS; PROTEOGLYCANS; RATS; TUMOR CELLS, CULTURED;

EID: 0031918209     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006505211766     Document Type: Article

References (28)

1. Foulds L, 1957, Tumor progression. Cancer Res. 17, 355-6.
2. Nowell PC, 1986, Mechanisms of tumor progression. Cancer Res, 46, 2203-7.
3. Pitot HC, 1989, Progression: the terminal stage in carcinogenesis. Jpn J Cancer Res, 80, 599-607.
4. Nicolson GL, 1987, Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res, 47, 1473-87.
5. Hamada J, Takeichi N, Okada F, et al. 1992, Progression of weakly malignant clone cells derived from rat mammary carcinoma by host cells reactive to plastic plates. Jpn J Cancer Res, 83, 483-90.
6. Li X, Nagayasu H, Hamada J, Hosokawa M and Takeichi N, 1993. Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-β. Jpn J Cancer Res, 84, 1145-9.
7. Hamada J, Takeichi N and Kobayashi H, 1988, Metastatic capacity and intercellular communication between normal cells and metastatic cell clones derived from a rat mammary carcinoma. Cancer Res, 48, 5129-32.
8. Nakajima M, Welch DR, Belloni PN and Nicolson GL, 1987, Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 47, 4869-76.
9. Albini A, Iwamoto Y, Kleinman HK, et al. 1987, A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res, 47, 3239-45.
10. Nakajima M, DeChavigny A, Johnson CE, Hamada J, Stein CA and Nicolson GL, 1991, Suramin. A potent inhibitor of melanoma heparanase and invasion. J Biol Chem, 266, 9661-6.
11. Ohigashi H, Shinkai K, Mukai M, et al. 1989, In vitro invasion of endothelial cell monolayer by rat ascites hepatoma cells. Jpn J Cancer Res, 80, 818-21.
12. Repesh LA, 1989, A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis, 9, 192-208.
13. Hamada J, Cavanaugh PG, Lotan O and Nicolson GL, 1992, Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br J Cancer, 66, 349-54.
14. Houssen C and Dowdle EB, 1980, Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrate. Analyt Biochem, 102, 196-202.
15. Laemmli UK, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-5.
16. Ren J, Hamada J, Okada F, et al. 1990, Correlation between the presence of microvilli and the growth of metastatic potential of tumor cells. Jpn J Cancer Res, 81, 920-6.
17. Kishimoto T, Tavassoli M, Green R and Jacobsen DW, 1987, Receptors for transferrin and transcobalamin II display segregated distribution on microvilli of leukemia L1210 cells. Biochem Biophys Res Commun, 146, 1102-8.
18. Mori S, Akiyama T, Morishita Y, et al. 1987, Light and electron microscopical demonstration of c-erbB-2 gene product-like immunoreactivity in human malignant tumors. Virchows Arch, B, 54, 8-15.
19. Sporn MB and Roberts AB, 1986, Peptide growth factors and inflammation, tissue repair and cancer. J Clin Invest, 78, 329-32.
20. Wahl SM, Wong H and McCartney-Francis N, 1989, Role of growth factors in inflammation and repair. J Cell Biochem, 40, 193-9.
21. Babior BM and Woodman RC, 1990, Chronic granulomatous disease. Semin Hematol, 27, 247-59.
22. Hamada J, Takeichi N, Ren J and Kobayashi H, 1991, Junctional communication of highly and weakly metastatic variant clones from a rat mammary carcinoma in primary and metastatic sites. Invasion Metastasis, 11, 149-57.
23. Nicolson GL, Dulski KM and Trosko JE, 1988, Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells. Proc Nail Acad Sci USA, 85, 473-6.
24. Enomoto T, Sasaki Y, Shiba Y, Kanno Y and Yamasaki H, 1981, Tumor promoters cause a rapid and reversible inhibition of the formation and maintenance of electrical cell coupling in culture. Proc Natl Acad Sci USA, 78, 5628-32.
25. Yotti LP, Chang CC and Trosko JE, 1979, Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science, 206, 1089-91.
26. Enomoto T and Yamasaki H, 1985, Phorbol ester-mediated inhibition of intercellular communication in BALB/c3T3 cells: relationship to enhancement of cell transformation. Cancer Res, 45, 2681-8.
27. Chow DA, 1984, Variant generation and selection: an in vitro model of tumor progression. Int J Cancer, 33, 541-5.
28. Madhukar BV, Oh SY, Chang CC, Wade M and Trosko JE, 1989, Altered regulation of intercellular communication by epidermal growth factor, transforming growth factor-β, and peptide hormones in normal keratinocytes. Carcinogenesis, 10, 13-20.